NIH-funded research R01 grant

Understanding how plasma cells develop and survive in the bone marrow.

Official title: Human Plasma Cell Maturation & Maintenance through CD138, TNFRSF, and Modulation of Ig Secretion

Funded at Emory University · NIH-11011450 · Data updated 2026-11-12

This study is looking at how certain proteins help long-lived plasma cells survive in the bone marrow, which is important for keeping your body’s antibody levels up, and it could help us create better vaccines that give you lasting protection.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionEmory University
NIH-funded
Lab location1 site (Atlanta, United States)
Project startFebruary 21, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$748,742
NIH project number5R01AI172254-03
Project IDNIH-11011450 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over the age of 21 who may benefit from improved vaccine strategies.

Less likely to help

Patients who are under 21 years old or those with conditions that severely impair immune function may not benefit from this research.

What this research studies

This research investigates the mechanisms that allow long-lived plasma cells (LLPC) to thrive in the bone marrow, which are crucial for maintaining antibody levels in the body. The study focuses on specific proteins, such as CD138 and BCMA, that play significant roles in the transformation of early antibody-secreting cells into LLPC. By exploring various binding factors and their interactions within the bone marrow environment, the research aims to uncover how these cells can be sustained and how their antibody secretion can be modulated. This knowledge could lead to improved vaccine designs that provide long-lasting immunity.

Why it matters

Potential benefit: If successful, this research could enhance the effectiveness of vaccines by ensuring a more durable immune response.

How similar studies have gone: Previous research has shown promising results in understanding plasma cell biology, suggesting that this approach could lead to significant advancements in vaccine development.

Where this research is happening

  • Emory University
    Atlanta, United States
    Active

Researchers

  • Principal investigator: Lee, Frances Eun-Hyung — Emory University
  • Study coordinator: Lee, Frances Eun-Hyung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.